دورية أكاديمية

Neoadjuvant everolimus plus letrozole versus fluorouracil, epirubicin and cyclophosphamide for ER-positive, HER2-negative breast cancer: a randomized pilot trial

التفاصيل البيبلوغرافية
العنوان: Neoadjuvant everolimus plus letrozole versus fluorouracil, epirubicin and cyclophosphamide for ER-positive, HER2-negative breast cancer: a randomized pilot trial
المؤلفون: Wu, Wei, Chen, Jiewen, Deng, Heran, Jin, Liang, He, Zhanghai, Rao, Nanyan, Nie, Yan, Yao, Yandan, Yang, Yaping, Su, Fengxi, Liu, JieqiongAff1
المصدر: BMC Cancer. 21(1)
قاعدة البيانات: Springer Nature Journals